In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
about
Inositol Treatment and ART Outcomes in Women with PCOSD-chiro-inositol glycans in insulin signaling and insulin resistanceInsulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor.chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjectsDetermination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients.Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols.Genetic modification of Bacillus subtilis for production of D-chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome.Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndromeRelationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation.Pinitol supplementation does not affect insulin-mediated glucose metabolism and muscle insulin receptor content and phosphorylation in older humans.Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells.d- chiro-Inositol is absorbed but not synthesised in rodentsThe Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes.The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).Inositol, neural tube closure and the prevention of neural tube defects.
P2860
Q28077261-CD5AE74C-4FDC-41C5-ADCA-9FFCB53F957AQ30434215-0F25D40C-0980-4C03-AD19-E541A6350483Q30453988-56FB3146-C5F7-4686-994A-E7FC6626DD23Q30454048-CDDA0C4B-C039-4A95-948D-9546F89BAA84Q30454061-053F9D1A-931F-486F-83BC-3C4293250A05Q33628262-63D8D3F5-7331-4B09-B5DE-A5A8552FEF38Q33775146-45F3E7DD-70CB-479F-BB51-E8E8023A68B6Q34431425-80BD9733-09AD-47C4-8012-77335EF3B529Q35117211-791262CA-76C4-48A5-86E7-140095E6A643Q36311686-2B5B6EC9-E230-4B21-977A-A7EDD4201B7FQ36915041-A1E6D635-818C-435D-9F0D-845C7C447C92Q37066270-7C968620-7970-4647-B54C-7CE023D2BF71Q37140717-DBA8BCCC-3B19-444A-AB48-388E7E891FAFQ37363630-52C38C3B-4114-44CE-91B5-E02CB2850778Q37502964-3F75F0D8-193E-422D-B8D0-39648630AA9FQ54229439-C91E6B89-D487-4726-905E-8BEE56BA65A9
P2860
In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
@ast
In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
@en
type
label
In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
@ast
In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
@en
prefLabel
In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
@ast
In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
@en
P2093
P1476
In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues.
@en
P2093
P304
16904-16910
P407
P577
1992-08-01T00:00:00Z